Right Now
Hereditary Angioedema Market to Witness High Growth
Due to Rising Prevalence of Hereditary Angioedema Disease
The hereditary angioedema market is primarily driven by the
increasing prevalence of hereditary angioedema disease. Hereditary angioedema
is a rare genetic disease characterized by recurrent episodes of swelling that
affect areas of the skin or other tissues of the body like the intestines and
airways. The symptoms include swelling of the hands, feet, limbs or face along
with abdominal pain and vomiting. If swelling occurs in the throat or airway,
it can potentially lead to asphyxiation. Traditionally, therapies for
hereditary angioedema have focused on symptom management during acute attacks.
However, new therapies are now available that can prevent attacks from
occurring.
The global
hereditary angioedema market is estimated to be valued at US$ 3158.05 Mn in
2024 and is expected to exhibit a CAGR of 9.1% over the forecast period 2024 to
2031.
Key players operating in the hereditary angioedema market are CSL Behring,
Takeda Pharmaceutical Company Limited., Pharming, BIOCRYST PHARMACEUTICALS,
INC., Ionis Pharmaceuticals, Inc., Attune Pharmaceuticals, Arrowhead
Pharmaceuticals, Inc., Adverum Biotechnologies, Inc., KalVista Pharmaceuticals,
CENTOGENE N.V., and Sanofi.
Key opportunities in the market include advancements in drug development for
hereditary angioedema with several pipeline drugs under development. Companies
are developing subcutaneous and oral drugs that can prevent attacks from
occurring and improve treatment adherence over current therapies. The global
prevalence of hereditary angioedema is also expanding the market growth with
increasing diagnosis rates across countries.
The rising prevalence of hereditary angioedema disease is one of the major
market drivers. According to estimates, about 1 in 10,000 to 1 in 50,000 people
worldwide have hereditary angioedema. Increasing awareness about the disease
and its treatment options is also boosting the detection rates. In addition,
the approval and launch of newer prophylactic drugs for preventing attacks will
further fuel the market growth during the forecast period. The availability of
newer drug delivery formulations like subcutaneous injectables and oral pills
over current injectables is also expected to augment the adoption of preventive
therapies.
PEST Analysis
Political:
Regulations regarding the approval and marketing of medication have an impact
on the Hereditary
Angioedema Market Growth.
Economic: Cost of medication and ability of patients to afford treatment
influences market demand and size.
Social: Growing awareness about hereditary angioedema as a serious medical
condition drives patients to seek treatment options.
Technological: Advancements in treatment options from traditional medications
to gene therapy provide patients with various options for managing symptoms and
attacks. Developments in targeted drug delivery methods also increase efficacy
of treatment.
The North American region currently holds the largest share of the global hereditary
angioedema market in terms of value due to increasing diagnosis rates and
awareness along with availability of treatment options in the region.
The Asia Pacific region is anticipated to witness the fastest growth over the
forecast period owing to growing healthcare infrastructure, rising disposable
incomes, and expanding patient access to diagnosis and treatment in major
market countries like China and India.
Get more insights
on Hereditary
Angioedema Market
Explore more
Articles related Dental
Implants Market
For Deeper Insights, Find the Report in the
Language that You want
About
Author:
Ravina
Pandya, Content Writer,
has a strong foothold in the market research industry. She specializes in
writing well-researched articles from different industries, including food and
beverages, information and technology, healthcare, chemical and materials, etc.
More Posts
Report This Post
Please complete the following requested information to flag this post and report abuse, or offensive content. Your report will be reviewed within 24 hours. We will take appropriate action as described in Findit terms of use.
